cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLC10.15829/1728-8800-2006-0-1-32cardiovascular-1091Research ArticleСтатьиARTICLESЛечение острого коронарного синдрома без стойкого подъема сегмента ST на ЭКГ Российские рекомендациистатьяредакционная
Комитет экспертов
Всероссийское научное общество кардиологовRussian Federation20062001200600Лечение острого коронарного синдрома без стойкого подъема сегмента ST на ЭКГ.Российские рекомендации132Copyright © статья р., 20062006статья р.статья р.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/1091
.
ReferencesManagement of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology.Eur Heart J 2000; 21: 1406–32Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology.Eur Heart J 2000; 21: 1406–32Bertrand ME, Simoons ML, Fox KAA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2002; 23: 1809–40.Bertrand ME, Simoons ML, Fox KAA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2002; 23: 1809–40.Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). 2002. Available at: http://www.acc.org/clinical/guidelines/unstable/unstable.pdfBraunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). 2002. Available at: http://www.acc.org/clinical/guidelines/unstable/unstable.pdfACC/AHA Guidelines for the Management of Patients with Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). JACC 200; 36: 970–1062ACC/AHA Guidelines for the Management of Patients with Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). JACC 200; 36: 970–1062Hamm CW, Braunwald E. A classification of unstable angina revisited. Circulation, 2000; 102 (1): 118-22Hamm CW, Braunwald E. A classification of unstable angina revisited. Circulation, 2000; 102 (1): 118-22Myocardial Infarction Redefined—A Consensus Document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. JACC 2000; 36: 959-1062.Myocardial Infarction Redefined—A Consensus Document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. JACC 2000; 36: 959-1062.Antithrombotic Trialists’ Collaboration. Collaborative meta analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71–86.Antithrombotic Trialists’ Collaboration. Collaborative meta analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71–86.The Sixth (2000) ACCP Guidelines for Antithrombotic Therapy for Prevention and Treatment of Thrombosis. Chest 2001; 119: Suppl.The Sixth (2000) ACCP Guidelines for Antithrombotic Therapy for Prevention and Treatment of Thrombosis. Chest 2001; 119: Suppl.Hirsh J, Anand S, Halperin JL, Fuster V. Guide to anticoagulant therapy: Heparin. A statement for healthcare professionals from the American Heart Association. Circulation 2001; 103:2994-3018Hirsh J, Anand S, Halperin JL, Fuster V. Guide to anticoagulant therapy: Heparin. A statement for healthcare professionals from the American Heart Association. Circulation 2001; 103:2994-3018De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003; 17: 1601-10.De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003; 17: 1601-10.Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.Campeau L. Grading of angina pectoris. Circulation 1976; 54:522–3.Campeau L. Grading of angina pectoris. Circulation 1976; 54:522–3.Hirsh J, Warkentin TE, Shaugnessy SG, et al. Heparin and low weight heparin. Mechanism of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119: 64S- 94Hirsh J, Warkentin TE, Shaugnessy SG, et al. Heparin and low weight heparin. Mechanism of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119: 64S- 94ACC/AHA guidelines for percutaneous coronary intervention (Revision of the 1993 PTCA guidelines) – executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). Circulation 2001; 103: 3019-41ACC/AHA guidelines for percutaneous coronary intervention (Revision of the 1993 PTCA guidelines) – executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). Circulation 2001; 103: 3019-41Kereiakes DJ, Montalescot G, Antman EM, et al. Low-molecular-weidht heparin therpy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus. Am Heart J. 2002; 144(4): 615-24Kereiakes DJ, Montalescot G, Antman EM, et al. Low-molecular-weidht heparin therpy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus. Am Heart J. 2002; 144(4): 615-24
The authors declare that there are no conflicts of interest present.